Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations / Tausch, Eugen; Ljungström, Viktor; Agathangelidis, Andreas; Zapatka, Marc; Scarfò, Lydia; Jebaraj, Billy Michael Chelliah; Yosifov, Deyan Y; Müller, Annika; Munugalavadla, Veerendra; Degenhardt, Jeremiah D; Ghia, Paolo; Rosenquist, Richard; Stilgenbauer, Stephan. - In: BLOOD. - ISSN 1528-0020. - 139:22(2022), pp. 3340-3344. [10.1182/blood.2021014550]
Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations
Scarfò, Lydia;Ghia, Paolo
;
2022-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
